Teva’s strategy to boost its operational efficiency and tap strategic partnerships seems to be paying off. In its Q3 earnings report, Teva announced that global revenues were up to $3.9 billion, marking a 7% rise from the previous year’s third quarter. Factors fueling the growth include the robust performance of their specialty medications, Austedo and…
Transparency-Rx promises reform in the PBM landscape
Pharmacy benefit managers (PBMs) have recently emerged as a punching bag with the pharma trade group PhRMA accusing such orgs of driving up drug prices. Now, an alliance of PBMs known as Transparency-Rx has emerged, promising a reform initiative in a digital campaign attempting to put pressure on rival PBMs. This coalition’s efforts could reshape…
Survey: Cybersecurity is top concern of pharma C-suites
Cybersecurity is a concern for two-thirds of pharmaceutical C-suites (66%), according to a recent survey from Rackspace and Microsoft. The priority came ahead of supply chain/logistics management (55%) and sustainability (53%). See full data below: Data breaches in the pharma sector are costly, with the average cost of remediation topping $10 million in 2022, according…
PBMs increasingly under fire in drug-pricing battle
As the national debate over drug pricing ramps up, Pharmacy Benefit Managers (PBMs) find themselves squarely in the spotlight. PhRMA, which has also criticized hospitals for marking up drug prices by as much as 500%, launched a seven-figure ad campaign targeting proposals in Congress to lower drug prices. PhRMA, which counts companies such as Pfizer,…
An interactive look at the drugs accounting for a fifth of Medicare’s spending
As Medicare prepares to negotiate drug prices directly with pharma companies, the White House has selected 10 drugs that make up 20% — one-fifth — of Medicare’s annual spending. Our analysis provides a deep dive into these drugs, including their costs, the number of enrollees depending on them and the significant price hikes since their…
Gilead wins ruling in battle against alleged counterfeiters in HIV drug case
A federal judge ruled against two defendants accused of selling counterfeit HIV medications, denying their motions to lift existing asset freezes obtained by pharmaceutical company Gilead Sciences in the ongoing lawsuit. Judge Ann M. Donnelly of the United States District Court for the Eastern District of New York converted the temporary asset freezes into preliminary…
The impact of the Virginia life sciences boom on pharmaceutical manufacturing
Virginia is emerging as a hotspot for pharmaceutical manufacturing, attracting a growing number of industry players. The privately-held pharma manufacturing organizations Civica and Phlow have a presence in the state, as do Big Pharma heavyweight Merck & Co. (NYSE:MRK) and AMPAC Fine Chemicals (NYSE:AMPA). The latter company produces active pharmaceutical ingredients and intermediates for the…
Sanofi joins Lilly and Novo Nordisk in drastic insulin price reductions
Paris-based Sanofi (Nasdaq:SNY) is the fastest company to reduce insulin prices. The pharmaceutical behemoth said it would cut the list price of Lantus (insulin glargine injection) by 78%. Lantus is its most commonly prescribed insulin in the U.S. Moreover, Sanofi will implement a $35 cap on out-of-pocket expenses for users of the insulin. Sanofi has also…
ADHD drug shortage deepens as demand reaches new highs
The national ADHD drug shortage has entered its fifth month, leaving people who rely on medications like Adderall with few alternatives. The shortage has also affected other drugs, including Concerta, Ritalin, and Vyvanse. Factors contributing to the ADHD drug shortage ADHD diagnoses have surged during the pandemic. The DEA limits the production of ADHD, which…
Cardinal Health, Palantir partner on AI for pharmaceutical products
Cardinal Health (NYSE:CAH) announced that it entered into a strategic collaboration with Palantir Technologies (NYSE:PLTR). The partnership pairs the companies to design a solution to give health systems and hospitals dynamic purchase decision insights. These insights help them quickly improve their bottom line. Dublin, Ohio-based Cardinal Health plans to integrate this solution into Foundry, Palantir’s…